Ticker >

Ajooni Biotech share price

Ajooni Biotech Ltd.

NSE: AJOONI SECTOR: Animal Feed  25k   45   6

6.45
+0.10 (1.57%)
NSE: Today, 10:54 AM

Price Summary

Today's High

₹ 6.6

Today's Low

₹ 6.35

52 Week High

₹ 7.7

52 Week Low

₹ 3.85

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

56.51 Cr.

Enterprise Value

61.38 Cr.

No. of Shares

8.76 Cr.

P/E

31.62

P/B

1.32

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  4.9

CASH

0.31 Cr.

DEBT

5.18 Cr.

Promoter Holding

26.44 %

EPS (TTM)

₹  0.2

Sales Growth

0.61%

ROE

3.87 %

ROCE

5.99%

Profit Growth

7.24 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year0.61%
3 Year23%
5 Year11.94%

Profit Growth

1 Year7.24%
3 Year48.02%
5 Year23.84%

ROE%

1 Year3.87%
3 Year4.28%
5 Year3.82%

ROCE %

1 Year5.99%
3 Year6.72%
5 Year5.67%

Debt/Equity

0.1242

Price to Cash Flow

-10.13

Interest Cover Ratio

4.29667572653147

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 26.44 0
Dec 2023 26.44 0
Sep 2023 27.46 0
Jun 2023 30.28 0
Mar 2023 36.39 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 22.9955214131681% for the Past 3 years.
  • The company has an efficient Cash Conversion Cycle of 68.865139595986 days.
  • Company has a healthy liquidity position with current ratio of 2.27958184029718.

 Limitations

  • Company has a poor ROE of 4.28315548150431% over the past 3 years.
  • Company has negative cash flow from operations of -5.579.
  • The company has a low EBITDA margin of 3.17802102055768% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 10.63 41.26 21 19.48 20.05
Total Expenditure 10.16 40.31 20.34 18.84 20.71
Operating Profit 0.48 0.94 0.67 0.64 -0.66
Other Income 0.02 0.26 0.07 0.29 1.57
Interest 0.13 0.12 0.13 0.19 0.12
Depreciation 0.26 0.24 0.21 0.21 0.21
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.11 0.85 0.4 0.52 0.58
Tax 0 0.31 -0.01 0.12 0.14
Profit After Tax 0.11 0.54 0.4 0.41 0.44
Adjusted EPS (Rs) 0.01 0.06 0.05 0.05 0.05

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 39.72 40.03 51.04 74.04 74.49
Total Expenditure 39.01 38.82 49.39 70.96 71.72
Operating Profit 0.71 1.21 1.65 3.07 2.77
Other Income 0.34 0.09 0.02 0.04 0.29
Interest 0.13 0.33 0.58 0.54 0.48
Depreciation 0.44 0.49 0.58 1.11 1
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.47 0.48 0.5 1.46 1.58
Tax 0.06 0.13 0.13 0.41 0.45
Net Profit 0.41 0.35 0.37 1.05 1.12
Adjusted EPS (Rs.) 0.12 0.07 0.07 0.21 0.13

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 6.16 8.41 10.01 10.01 17.52
Total Reserves 6.01 7.49 5.65 6.38 24.15
Borrowings 4.16 1.33 1.9 2.58 1.75
Other N/C liabilities -0.09 -0.13 -0.15 -0.18 -0.17
Current liabilities 1.93 5.85 10.48 10.06 15.21
Total Liabilities 18.16 22.94 27.88 28.84 58.46
Assets
Net Block 1.02 2.07 3.6 6.21 6.29
Capital WIP 0 0 1.57 0 0.26
Intangible WIP 0 0 0 0 0
Investments 3.76 3.08 1.15 0.7 3.74
Loans & Advances 1.12 0 0 0 1.5
Other N/C Assets 0.42 0.28 0.14 0 12
Current Assets 11.83 17.51 21.43 21.93 34.67
Total Assets 18.16 22.94 27.88 28.84 58.46
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 0.47 0.48 0.5 1.46 1.58
Adjustment 0.28 0.64 1.02 1.66 1.38
Changes in Assets & Liabilities -5.55 -5.5 -0.36 0.72 -8.09
Tax Paid -0.12 0 -0.01 -0.16 -0.45
Operating Cash Flow -4.92 -4.38 1.16 3.68 -5.58
Investing Cash Flow 1.42 0.47 -3.41 -1.9 -15.82
Financing Cash Flow -1.06 3.3 2.37 -1.97 21.66
Net Cash Flow -4.57 -0.61 0.12 -0.19 0.25

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 36.39 30.28 27.46 26.44 26.44
ashmeet kaur 3.63 3.63 3.63 3.63 3.63
healthy biosciences limit... - - - - 0.01
ishneet kaur 0.61 0.61 0.28 0.05 0.05
jasjot singh 20.03 17.74 15.61 15.16 15.16
parmjeet kaur 3.63 3.63 3.63 3.63 3.63
upneet kaur 5.89 4.67 4.30 3.96 3.96
healthy biosciences limit... - - - 0.01 -
healthy biosciences priva... 2.61 0.01 0.01 - -
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 63.61 69.72 72.54 73.56 73.56
chako jacob - - - - 1.00
chacko jacob - - 1.00 1.00 -
madhukar sheth 1.20 1.20 1.20 1.20 -
monifest capital private ... 1.03 1.03 1.03 1.03 -
satish parasmal jain 1.32 1.28 1.28 - -
chirag d bhanushali - huf... - 1.14 - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Ajooni Biotech bags order from Avon Animal Health22 Apr 2024, 11:30AM Ajooni Biotech inks pact with NDDB Dairy Services 13 Apr 2024, 4:04PM Ajooni Biotech - Quaterly Results7 Feb 2024, 12:00PM Ajooni Biotech - Quaterly Results7 Feb 2024, 12:00PM Ajooni Biotech - Quaterly Results7 Feb 2024, 12:00PM Ajooni Biotech - Quaterly Results3 Aug 2023, 12:00PM Ajooni Biotech - Quaterly Results3 Aug 2023, 12:00PM Ajooni Biotech - Quaterly Results3 Aug 2023, 12:00PM Ajooni Biotech - Quaterly Results18 May 2023, 12:00PM Ajooni Biotech - Quaterly Results18 May 2023, 12:00PM Ajooni Biotech inks agreement with Mooofarm3 Mar 2023, 2:47PM Ajooni Biotech - Quaterly Results14 Feb 2023, 12:00PM Ajooni Biotech - Quaterly Results14 Feb 2023, 12:00PM Ajooni Biotech launches AJOONI Brand feed globally30 Nov 2022, 2:07PM Ajooni Biotech develops lumpy skin disease medicine for cattle7 Sep 2022, 11:50AM Ajooni Biotech awarded most progressive animal health care solution company29 Aug 2022, 4:11PM Ajooni Biotech acquires new land for production of veterinary feed supplements, antibiotics18 Aug 2022, 11:22AM Ajooni Biotech - Quaterly Results5 Aug 2022, 12:00PM Ajooni Biotech - Quaterly Results5 Aug 2022, 12:00PM Ajooni Biotech - Quaterly Results5 Aug 2022, 12:00PM Ajooni Biotech, Harit Pradesh MPCL enter into agreement8 Jun 2022, 2:21PM Ajooni Biotech - Quaterly Results9 May 2022, 12:00PM Ajooni Biotech - Quaterly Results9 May 2022, 12:00PM Ajooni Biotech - Quaterly Results9 May 2022, 12:00PM Ajooni Biotech enters into 3-year agreement with IKSL5 Apr 2022, 2:38PM Ajooni Biotech - Quaterly Results11 Feb 2022, 12:00PM Ajooni Biotech - Quaterly Results11 Feb 2022, 12:00PM Ajooni Biotech, IKSL enter into strategic, exclusive agreement9 Feb 2022, 11:59AM Ajooni Biotech to set up Oxygen Park5 Jul 2021, 11:27AM

Ajooni Biotech Stock Price Analysis and Quick Research Report. Is Ajooni Biotech an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Ajooni Biotech . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Ajooni Biotech has a PE ratio of 31.1274509803922 which is high and comparatively overvalued .

  • Share Price: - The current share price of Ajooni Biotech is Rs 6.35. One can use valuation calculators of ticker to know if Ajooni Biotech share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Ajooni Biotech has ROA of 2.57677398069997 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Ajooni Biotech has a Current ratio of 2.27958184029718 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Ajooni Biotech has a ROE of 3.87482192597288 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Ajooni Biotech has a Debt to Equity ratio of 0.1242 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Ajooni Biotech has reported revenue growth of 0.607662572361667 % which is poor in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Ajooni Biotech for the current financial year is 3.71323050651316 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Ajooni Biotech is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Ajooni Biotech is Rs 0.204 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Ajooni Biotech in Ticker for free. Also, one can get the intrinsic value of Ajooni Biotech by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Ajooni Biotech
X